Research and Clinical Trials

Researchers within the Division of Transplantation at the University of Maryland Medical Center areDr. Barth in lab committed to investigating new ways to advance the science of transplantation and ensure better futures for patients in need of transplant or for those who are already living with organ transplants.

The research within the Division of Transplantation falls into several categories: 

  • Inducing tolerance - teaching the body to accept a foreign graft, such as a transplanted organ, without rejection and with limited or no immunosuppression. 
  • Immunosuppression medications and medication management - testing the latest medications or combinations of medications to prevent rejection while reducing the "pill burden" on patients and creating protocols that demonstrate long-term success with fewer side effects.
    • See clinical trial for aerosol version of cyclosporine for lung recipients. 
  • Increasing the number of available donor organs - through tissue regeneration and systematic sourcing of available organs.
  • Advancements in surgical technique - use of new operative tools, materials and techniques, including the single-incision laparoscopic surgery used on living kidney donors. 
    • See paper published on single-port donor nephrectomy through belly button and watch video. 
  • Using bone marrow-derived stem cells to decrease rejection - could help eliminate need for immunosuppression in all types of organ recipients.
  • Bridge-to-transplant technology - medical devices used to help patients who are in need of transplant but either not at the top of the wait list or without an available donor organ. 


This page was last updated: August 11, 2014

         
Average rating (0)